IBDEI0CG ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5700,0)
 ;;=I67.89^^30^380^14
 ;;^UTILITY(U,$J,358.3,5700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5700,1,3,0)
 ;;=3^Cerebrovascular Disease,Oth
 ;;^UTILITY(U,$J,358.3,5700,1,4,0)
 ;;=4^I67.89
 ;;^UTILITY(U,$J,358.3,5700,2)
 ;;=^5007388
 ;;^UTILITY(U,$J,358.3,5701,0)
 ;;=J32.8^^30^380^50
 ;;^UTILITY(U,$J,358.3,5701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5701,1,3,0)
 ;;=3^Sinusitis,Chr,Oth
 ;;^UTILITY(U,$J,358.3,5701,1,4,0)
 ;;=4^J32.8
 ;;^UTILITY(U,$J,358.3,5701,2)
 ;;=^269890
 ;;^UTILITY(U,$J,358.3,5702,0)
 ;;=J32.4^^30^380^49
 ;;^UTILITY(U,$J,358.3,5702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5702,1,3,0)
 ;;=3^Pansinusitis,Chr
 ;;^UTILITY(U,$J,358.3,5702,1,4,0)
 ;;=4^J32.4
 ;;^UTILITY(U,$J,358.3,5702,2)
 ;;=^5008206
 ;;^UTILITY(U,$J,358.3,5703,0)
 ;;=J40.^^30^380^9
 ;;^UTILITY(U,$J,358.3,5703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5703,1,3,0)
 ;;=3^Bronchitis,Unspec
 ;;^UTILITY(U,$J,358.3,5703,1,4,0)
 ;;=4^J40.
 ;;^UTILITY(U,$J,358.3,5703,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,5704,0)
 ;;=J45.909^^30^380^4
 ;;^UTILITY(U,$J,358.3,5704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5704,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,5704,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,5704,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,5705,0)
 ;;=J44.9^^30^380^10
 ;;^UTILITY(U,$J,358.3,5705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5705,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,5705,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,5705,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,5706,0)
 ;;=K21.9^^30^380^22
 ;;^UTILITY(U,$J,358.3,5706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5706,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,5706,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,5706,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,5707,0)
 ;;=N40.0^^30^380^21
 ;;^UTILITY(U,$J,358.3,5707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5707,1,3,0)
 ;;=3^Enlarged Prostate w/o LUTS
 ;;^UTILITY(U,$J,358.3,5707,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,5707,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,5708,0)
 ;;=N40.1^^30^380^20
 ;;^UTILITY(U,$J,358.3,5708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5708,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,5708,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,5708,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,5709,0)
 ;;=L03.811^^30^380^11
 ;;^UTILITY(U,$J,358.3,5709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5709,1,3,0)
 ;;=3^Cellulitis,Head (Except Face)
 ;;^UTILITY(U,$J,358.3,5709,1,4,0)
 ;;=4^L03.811
 ;;^UTILITY(U,$J,358.3,5709,2)
 ;;=^5009063
 ;;^UTILITY(U,$J,358.3,5710,0)
 ;;=L03.818^^30^380^12
 ;;^UTILITY(U,$J,358.3,5710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5710,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,5710,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,5710,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,5711,0)
 ;;=L03.891^^30^380^36
 ;;^UTILITY(U,$J,358.3,5711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5711,1,3,0)
 ;;=3^Lymphangitis,Head (Except Face),Acute
 ;;^UTILITY(U,$J,358.3,5711,1,4,0)
 ;;=4^L03.891
 ;;^UTILITY(U,$J,358.3,5711,2)
 ;;=^5009065
 ;;^UTILITY(U,$J,358.3,5712,0)
 ;;=L03.898^^30^380^37
 ;;^UTILITY(U,$J,358.3,5712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5712,1,3,0)
 ;;=3^Lymphangitis,Oth Sites,Acute
 ;;^UTILITY(U,$J,358.3,5712,1,4,0)
 ;;=4^L03.898
 ;;^UTILITY(U,$J,358.3,5712,2)
 ;;=^5009066
 ;;^UTILITY(U,$J,358.3,5713,0)
 ;;=L03.90^^30^380^13
 ;;^UTILITY(U,$J,358.3,5713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5713,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,5713,1,4,0)
 ;;=4^L03.90
